Why Do I Still Have Brain Fog and Fatigue After Mold Exposure or Leaving a Water-Damaged Building?
Quick Answer
Leaving the building removes the trigger, but in a genetically susceptible subset of people it doesn't remove the problem. Their immune system can't properly tag mold-derived biotoxins for clearance, so the toxins keep recirculating and the inflammatory cascade they set off keeps running on its own. That's what Chronic Inflammatory Response Syndrome (CIRS) describes, and it's a real, treatable, biomarker-trackable process, not something you're imagining because a doctor couldn't find anything on standard labs.
Certain HLA-DR haplotypes can't clear mold-derived biotoxins, so they recirculate through the enterohepatic pathway and the innate immune system stays activated indefinitely, which is why symptoms can persist for months or years after the exposure itself ends.
This is a real, diagnosable, treatable process, but confirming it and treating it correctly both depend on tracking specific lab markers in a specific order. The full diagnostic workup, what the evidence actually supports, and exactly how treatment is sequenced (including where VIP fits) are covered in the full guide: Mold Illness and CIRS →
If you've been dealing with unexplained fatigue and brain fog since a known water-damaged building exposure, or symptoms that never fully resolved after you left one, I can walk you through the diagnostic workup and, if it's indicated, the full sequenced treatment plan. Here are all of the practices I see patients in. Prefer to start with a question first? Reach out directly by email or Instagram.
View My Clinic LocationsOr email drwilcox@precisionhormoneconsulting.com · DM @wellnessdoc_4everyoung on Instagram
Dr. Darrell Wilcox · @wellnessdoc_4everyoung on Instagram
References
Full citations for the diagnostic and treatment evidence discussed above are in the Mold Illness and CIRS guide.
This content is for educational purposes only and does not constitute medical advice. Chronic Inflammatory Response Syndrome is not currently a formally recognized diagnosis in the ICD-10-CM and is not endorsed as a distinct clinical entity by mainstream allergy, immunology, or infectious disease societies; the evidence summarized above should be weighed accordingly. VIP is not FDA-approved for any indication; its regulatory compounding status is under an interim policy that has changed twice in 2026 and may change again. Individual clinical decisions require physician evaluation and are made on a case-by-case basis. Dr. Wilcox is licensed to practice in multiple states. See About for current licensure.